Abstract
Leishmania parasites rely heavily upon membrane transport proteins to deliver essential nutrients from their hosts to the interior of the parasite. Some of these transporters also serve as routes for uptake of drugs used for treatment of leishmaniasis or experimental drugs with potentialfor development of novel anti-leishmanial therapies. Hence, mutations within the coding regions of such permeases or alterations in the expression of the carrier proteins can confer drug resistance upon the parasites. This chapter reviews the current level of knowledge regarding several classes of membrane transporters known to play roles in uptake or sensitivity to drugs. The increasing knowledge of the ’permeome,– provided by complete genome sequences of several Leishmania species, has advanced considerably our knowledge of how nutrients and drugs or other cytotoxic compounds enterthese pathogenic protozoa.
Original language | English (US) |
---|---|
Title of host publication | Drug Resistance in Leishmania Parasites |
Subtitle of host publication | Consequences, Molecular Mechanisms and Possible Treatments |
Publisher | Springer-Verlag Wien |
Pages | 259-284 |
Number of pages | 26 |
ISBN (Electronic) | 9783709111253 |
ISBN (Print) | 9783709102381 |
DOIs | |
State | Published - Jan 1 2013 |
ASJC Scopus subject areas
- General Medicine